Caricamento...
In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis
BACKGROUND: Indications for use of tolvaptan in SIADH-associated hyponatraemia remain controversial. We audited our local guidelines for Tolvaptan use in this situation to review treatment implications including drug safety, hospital admission episode analysis (episodes of liver toxicity, CNS myelin...
Salvato in:
| Pubblicato in: | BMC Endocr Disord |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5674865/ https://ncbi.nlm.nih.gov/pubmed/29110656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-017-0214-2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|